Sorry, you need to enable JavaScript to visit this website.
Skip to main content
Congressional Testimony

Drug Shortages: FDA's Ability to Respond Should Be Strengthened.

Testimony before the Committee on Health, Education, Labor, and Pensions, US Senate. US Government Accountability Office. GAO-12-315T (December 15, 2011)

Save
Print
January 4, 2012
Testimony before the Committee on Health, Education, Labor, and Pensions, US Senate. US Government Accountability Office. GAO-12-315T (December 15, 2011)
View more articles from the same authors.

This testimony details the US Food and Drug Administration (FDA) response to drug shortage trends and advocates for the agency to have more leverage with manufacturers to address burgeoning shortages.

Save
Print
Cite
Citation

Testimony before the Committee on Health, Education, Labor, and Pensions, US Senate. US Government Accountability Office. GAO-12-315T (December 15, 2011)

Related Resources From the Same Author(s)
Related Resources